Resatorvid

瑞沙托维

Report date: 2025/03/26 20:01:25
NME

Base Information

Drug NameResatorvid
Drug Alias NameResatorvidumCompound(R)-(+)-5nCLI-095TAK-242TAK-242-NP +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 4 antagonists
TargetsToll like receptor 4
Therapy Area/IndicationsLiver Cirrhosis, AlcoholicHepatitis, AlcoholicAcute-On-Chronic Liver Failure +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[17] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAkaza Bioscience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYaqrit Ltd
Inactive CompaniesTakeda Pharmaceutical Co LtdAkaza Bioscience Ltd
Active IndicationsLiver Cirrhosis, AlcoholicHepatitis, AlcoholicAcute-On-Chronic Liver Failure
Inactive IndicationsSepsis

Other Information

ATC CodeN/A
Related LinksN/A